Hederagenin Alleviates Ulcerative Colitis via Suppressing the Activation of EGFR/p38 MAPK Signaling
Journal of Gastroenterology and Hepatology · 2026-06 · 41 (6) · 1811-1824
DOI: 10.1111/jgh.70403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 13.05.2026. Verfasst von Lu Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, ErbB Receptors, p38 Mitogen-Activated Protein Kinases, Oleanolic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Hederagenin (HDG) has been reported to attenuate the development of inflammatory diseases. Herein, we explored the functions and potential mechanisms of HDG on ulcerative colitis.
Methods
We established an ulcerative colitis model in mouse using 3% dextran sulfate sodium (DSS) and in IEC‐6 cells using LPS. Body weight, disease activity index (DAI) score, and colon length were recorded, and histopathological changes of colon tissues were observed using hematoxylin and eosin (HE) staining. The expression of pro‐inflammatory and anti‐inflammatory factors in colitic mice and IEC‐6 cells was detected by ELISA and qRT‐PCR. Moreover, we also detected the effect of HDG on the levels of GSH, SOD, and CAT in DSS‐treated mice. Subsequently, the influences of HDG on intestinal barrier impairment were explored by using western blot and immunofluorescence. Next, network pharmacology analysis, RNA sequencing analysis, western blot, immunofluorescence, and rescue experiments were utilized to explore the latent mechanisms of HDG on ulcerative colitis.
Results
HDG alleviated DSS‐induced ulcerative colitis in mice via ameliorating intestinal barrier impairment, inflammation, and oxidative stress. HDG also improved epithelial barrier function and inflammatory responses in LPS‐stimulated IEC‐6 cells. Besides, we discovered that HDG could inhibit the activation of EGFR/p38 MAPK signaling. Subsequently, rescue experiments using NSC228155 or anisomycin revealed that HDG could improve epithelial barrier function and inflammation via suppressing the activation of the EGFR/p38 MAPK pathway in LPS‐induced IEC‐6 cells.
Conclusion
Our results demonstrated that HDG could alleviate ulcerative colitis by inhibiting the activation of EGFR/p38 MAPK signaling, improving epithelial barrier function, and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Department of Gastroenterology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Department of Classical Chinese Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- School of First Clinical Medical, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Department of Anorectal Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
ORCID-Profile: Qinyuan Zhang
Zitieren
APA
Jiang, L., Lin, W., Zhao, Y., Xue, T., Chi, C., & Zhang, Q. (2026). Hederagenin Alleviates Ulcerative Colitis via Suppressing the Activation of EGFR/p38 MAPK Signaling. Journal of Gastroenterology and Hepatology, 41(6), 1811-1824. https://doi.org/10.1111/jgh.70403
Vancouver
Jiang L, Lin W, Zhao Y, Xue T, Chi C, Zhang Q. Hederagenin Alleviates Ulcerative Colitis via Suppressing the Activation of EGFR/p38 MAPK Signaling. Journal of Gastroenterology and Hepatology. 2026;41(6):1811-1824. doi:10.1111/jgh.70403
BibTeX
@article{Jiang2026,
author = {Jiang, Lu and Lin, Weigang and Zhao, Yujie and Xue, Tiancheng and Chi, Chunhua and Zhang, Qinyuan},
title = {Hederagenin Alleviates Ulcerative Colitis via Suppressing the Activation of EGFR/p38 MAPK Signaling},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {6},
pages = {1811--1824},
doi = {10.1111/jgh.70403}
}
EUVIMED